Irradiated tumor cell–derived microparticles mediate tumor eradication via cell killing and immune reprogramming
出版年份 2020 全文链接
标题
Irradiated tumor cell–derived microparticles mediate tumor eradication via cell killing and immune reprogramming
作者
关键词
-
出版物
Science Advances
Volume 6, Issue 13, Pages eaay9789
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2020-03-26
DOI
10.1126/sciadv.aay9789
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
- (2019) Qian Chen et al. ADVANCED MATERIALS
- Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer
- (2019) Sunil Singhal et al. Science Translational Medicine
- The release and activity of HMGB1 in ferroptosis
- (2019) Qirong Wen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The molecular machinery of regulated cell death
- (2019) Daolin Tang et al. CELL RESEARCH
- Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel
- (2018) Honglin Jin et al. ACS Nano
- Circulating tumor microparticles promote lung metastasis by reprogramming inflammatory and mechanical niches via a macrophage-dependent pathway
- (2018) Huafeng Zhang et al. Cancer Immunology Research
- Autophagy-Src Regulates Connexin43-Mediated Gap Junction Intercellular Communication in Irradiated HepG2 Cells
- (2018) Xiaoyao Yang et al. RADIATION RESEARCH
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
- (2018) Ioanna Keklikoglou et al. NATURE CELL BIOLOGY
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells
- (2018) Saurabh Kirolikar et al. Cell Death & Disease
- Cysteine protease cathepsin B mediates radiation-induced bystander effects
- (2017) Yu Peng et al. NATURE
- Radiotherapy combination opportunities leveraging immunity for the next oncology practice
- (2016) Fernanda G. Herrera et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
- (2016) Michael B. Bernstein et al. Nature Reviews Clinical Oncology
- Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
- (2016) D. Mathios et al. Science Translational Medicine
- Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression
- (2016) Ruihua Ma et al. OncoImmunology
- Expanding global access to radiotherapy
- (2015) Rifat Atun et al. LANCET ONCOLOGY
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Malignant Pleural Effusion
- (2012) Georgios T. Stathopoulos et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Survival of lung adenocarcinoma patients with malignant pleural effusion
- (2012) Shang-Gin Wu et al. EUROPEAN RESPIRATORY JOURNAL
- Delivery of chemotherapeutic drugs in tumour cell-derived microparticles
- (2012) Ke Tang et al. Nature Communications
- Honokiol Nanoparticles in Thermosensitive Hydrogel: Therapeutic Effects on Malignant Pleural Effusion
- (2009) Fang Fang et al. ACS Nano
- Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion
- (2008) Georgios T. Stathopoulos et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started